Jul 21, 2008
Story Timeline: 82 days
Date Published: Monday, July 21st, 2008 , the vaccine approved to target the human papillomavirus (HPV) is being criticized again for possible links to a 20-year-old woman who suffered a stroke after receiving a second Gardasil injection. Gardasil was approved by the US Food and Drug Administration (FDA) two years ago for girls aged nine-26 and protects against sexually transmitted diseases caused by four particularly dangerous HPV strains in women that are responsible for 70 percent of cervical cancers and 90 percent of genital warts. Merck & Company—Gardasil’s maker—said 16 million doses have been administered since its approval. Last month, Merck added more possible adverse reactions to Gardasiil’s growing list, including fatigue, weakness, and muscle pain; however, many feel this is not enough. Mary Davison daughter...
[read full story]